These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 29286135)

  • 1. Characterization of different osteoclast phenotypes in the progression of bone invasion by oral squamous cell carcinoma.
    Quan J; Hou Y; Long W; Ye S; Wang Z
    Oncol Rep; 2018 Mar; 39(3):1043-1051. PubMed ID: 29286135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MCP-1 as a potential target to inhibit the bone invasion by oral squamous cell carcinoma.
    Quan J; Morrison NA; Johnson NW; Gao J
    J Cell Biochem; 2014 Oct; 115(10):1787-98. PubMed ID: 24905457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of E-cadherin by monocytes from tumour cells plays key roles in the progression of bone invasion by oral squamous cell carcinoma.
    Quan J; Du Q; Hou Y; Wang Z; Zhang J
    Oncol Rep; 2017 Aug; 38(2):850-858. PubMed ID: 28656299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretion of IL-6 and IL-8 from lysophosphatidic acid-stimulated oral squamous cell carcinoma promotes osteoclastogenesis and bone resorption.
    Hwang YS; Lee SK; Park KK; Chung WY
    Oral Oncol; 2012 Jan; 48(1):40-8. PubMed ID: 21925926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular pathways involved in crosstalk between cancer cells, osteoblasts and osteoclasts in the invasion of bone by oral squamous cell carcinoma.
    Quan J; Zhou C; Johnson NW; Francis G; Dahlstrom JE; Gao J
    Pathology; 2012 Apr; 44(3):221-7. PubMed ID: 22406484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of YM529 on a model of mandibular invasion by oral squamous cell carcinoma in mice.
    Cui N; Nomura T; Noma H; Yokoo K; Takagi R; Hashimoto S; Okamoto M; Sato M; Yu G; Guo C; Shibahala T
    Clin Cancer Res; 2005 Apr; 11(7):2713-9. PubMed ID: 15814653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma.
    Michigami T; Ihara-Watanabe M; Yamazaki M; Ozono K
    Cancer Res; 2001 Feb; 61(4):1637-44. PubMed ID: 11245477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
    Michael H; Härkönen PL; Väänänen HK; Hentunen TA
    J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCL2 synthesized by oral squamous cell carcinoma is involved in cancer-associated bone destruction.
    Oue E; Lee JW; Sakamoto K; Iimura T; Aoki K; Kayamori K; Michi Y; Yamashiro M; Harada K; Amagasa T; Yamaguchi A
    Biochem Biophys Res Commun; 2012 Aug; 424(3):456-61. PubMed ID: 22771802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease status in autosomal dominant osteopetrosis type 2 is determined by osteoclastic properties.
    Chu K; Snyder R; Econs MJ
    J Bone Miner Res; 2006 Jul; 21(7):1089-97. PubMed ID: 16813529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The MET/Vascular Endothelial Growth Factor Receptor (VEGFR)-targeted Tyrosine Kinase Inhibitor Also Attenuates FMS-dependent Osteoclast Differentiation and Bone Destruction Induced by Prostate Cancer.
    Watanabe K; Hirata M; Tominari T; Matsumoto C; Fujita H; Yonekura K; Murphy G; Nagase H; Miyaura C; Inada M
    J Biol Chem; 2016 Sep; 291(40):20891-20899. PubMed ID: 27539855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells.
    Shin M; Matsuo K; Tada T; Fukushima H; Furuta H; Ozeki S; Kadowaki T; Yamamoto K; Okamoto M; Jimi E
    Carcinogenesis; 2011 Nov; 32(11):1634-40. PubMed ID: 21890459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-1β differently stimulates proliferation and multinucleation of distinct mouse bone marrow osteoclast precursor subsets.
    Cao Y; Jansen ID; Sprangers S; Stap J; Leenen PJ; Everts V; de Vries TJ
    J Leukoc Biol; 2016 Sep; 100(3):513-23. PubMed ID: 26957213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VEGF, FLT3 ligand, PlGF and HGF can substitute for M-CSF to induce human osteoclast formation: implications for giant cell tumour pathobiology.
    Taylor RM; Kashima TG; Knowles HJ; Athanasou NA
    Lab Invest; 2012 Oct; 92(10):1398-406. PubMed ID: 22906984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of NF-κB suppresses bone invasion by oral squamous cell carcinoma in vivo.
    Furuta H; Osawa K; Shin M; Ishikawa A; Matsuo K; Khan M; Aoki K; Ohya K; Okamoto M; Tominaga K; Takahashi T; Nakanishi O; Jimi E
    Int J Cancer; 2012 Sep; 131(5):E625-35. PubMed ID: 22262470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of a xenograft model to explore the mechanism of bone destruction by human oral cancers and its application to analysis of role of RANKL.
    Tohyama R; Kayamori K; Sato K; Hamagaki M; Sakamoto K; Yasuda H; Yamaguchi A
    J Oral Pathol Med; 2016 May; 45(5):356-64. PubMed ID: 26859422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of VEGF-Flt-1 signaling in malignant behaviors of oral squamous cell carcinoma.
    Subarnbhesaj A; Miyauchi M; Chanbora C; Mikuriya A; Nguyen PT; Furusho H; Ayuningtyas NF; Fujita M; Toratani S; Takechi M; Niida S; Takata T
    PLoS One; 2017; 12(11):e0187092. PubMed ID: 29149180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoregulation of RANK ligand in oral squamous cell carcinoma tumor cells.
    Sambandam Y; Ethiraj P; Hathaway-Schrader JD; Novince CM; Panneerselvam E; Sundaram K; Reddy SV
    J Cell Physiol; 2018 Aug; 233(8):6125-6134. PubMed ID: 29323724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoclast 121F antigen expression during osteoblast conditioned medium induction of osteoclast-like cells in vitro: relationship to calcitonin responsiveness, tartrate resistant acid phosphatase levels, and bone resorptive activity.
    Collin-Osdoby P; Oursler MJ; Rothe L; Webber D; Anderson F; Osdoby P
    J Bone Miner Res; 1995 Jan; 10(1):45-58. PubMed ID: 7747630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor-II mRNA binding protein-3 and podoplanin expression are associated with bone invasion and prognosis in oral squamous cell carcinoma.
    Hwang YS; Ahn SY; Moon S; Zheng Z; Cha IH; Kim J; Zhang X
    Arch Oral Biol; 2016 Sep; 69():25-32. PubMed ID: 27232357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.